Precigen Inc 's Revenue in the fiscal year 2025 $ 9.68 millions
Precigen Inc 's Revenue in the fiscal year 2024 $ 0.00 millions
Precigen Inc 's Revenue in the fiscal year 2023 $ 0.08 millions
Precigen Inc 's Revenue in the fiscal year 2022 $ 26.91 millions
Precigen Inc 's Revenue in the fiscal year 2021 $ 103.87 millions
PGEN Revenue first quarter 2026 Y/Y Growth Comment
Precigen Inc achieved in the first quarter 2026, above Company average Revenue surge of 1635.22% year on year, to $ 23.25 millions.
Looking into first quarter 2026 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Revenue growth. While Precigen Inc ' s Revenue doubling of 1635.22% ranks overall at the positon no. 37 in the first quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Precigen Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
474.44 %
56.07 %
-100 %
(Sep 30 2022)
PGEN's I. Quarter Q/Q Revenue Comment
Precigen Inc achieved in the I. Quarter 2026 above company average sequential Revenue doubling of 408.8%, to $ 23.25 millions, from $4.57 millions in the fourth quarter. PGEN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Precigen Inc 's Revenue growth quarter on quarter, overall rank is 42.
Precigen Inc achieved in the I. Quarter 2026 above company average sequential Revenue doubling of 408.8%, to $ 23.25 millions, from $4.57 millions in the fourth quarter. PGEN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Precigen Inc 's Revenue growth quarter on quarter, overall rank is 42.
Precigen Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
12 Months Ending (Mar 31 2025)
Cumulative Revenue 12 Months Ending
$ 31.60
$ 9.68
$ 0.00
$ 0.00
$ 0.00
Y / Y Revenue Growth (TTM)
-
-
-
-
-
Year on Year Revenue Growth Overall
Ranking
#
#
#
#
#
Seqeuential Revenue Change (TTM)
226.26 %
-
-
-
-
Seq. Revenue Growth (TTM) Overall
Ranking
# 63
# 0
# 0
# 0
# 0
Cumulative Revenue growth Comment
Precigen Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 1635.22% year on year, to $ 32 millions if the fiscal year would have ended in Mar 31 2026. Precigen Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Dec 31 2025. And, Precigen Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry. But from twelve months ended Dec 31 2025 rise was beneth at 226.26 % from $9.68 millions achieved in the period from Dec 31 2025 to Mar 31 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -69.99%.
Precigen Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
Precigen Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 1635.22% year on year, to $ 32 millions if the fiscal year would have ended in Mar 31 2026. Precigen Inc 's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Dec 31 2025. And, Precigen Inc realized the fastest Revenue growth, in Major Pharmaceutical Preparations industry. But from twelve months ended Dec 31 2025 rise was beneth at 226.26 % from $9.68 millions achieved in the period from Dec 31 2025 to Mar 31 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at -69.99%. The momentum is even more impressive from twelve months ended Dec 31 2025 exhibited at 226.26 % increase from $9.68 millions in the period from Dec 31 2025 to Mar 31 2025.
Precigen Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
About Precigen Inc Revenue Growth Rates (PGEN), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
2,683.55%